KŠB advised the seller on the sale of mcePharma to the Brenntag Group

The acquisition of mcePharma, a company focused on the development and production of innovative food supplements, complementary pet feed, and cosmetics, represents a strategic step for the Brenntag Group to strengthen its presence in the Life Sciences market in the EMEA region.
This was already the second successful sale of a company managed by Mr. Mikeš – we previously represented him in the sale of IMCoPharma to the Barentz Group.
Other articles
Jan Lasák chairs M&A FORUM 2026
KŠB partner Jan Lasák served as academic lead and moderator of M&A FORUM 2026, the eighth edition of the conference organised by Akademie C. H. Beck, held on 4 November at Stages Hotel Prague. The event has become a fixture in the Czech M&A calendar, bringing together leading practitioners from private practice, the judiciary, academia and in-house legal teams.
Richard Schmidt spoke at the Czech Competition Authority’s St. Martin's Conference 2026
KŠB attorney Richard Schmidt spoke at this year's St. Martin's Conference, hosted by the Czech Competition Authority (CCA) in Brno on 11–12 November 2026. The conference is a fixture of the Czech competition law calendar, drawing leading practitioners from home and abroad.